Iovance Biotherapeutics (IOVA) Misses Q3 EPS by 1c

Iovance Biotherapeutics (NASDAQ: IOVA) reported Q3 EPS of ($0.46), $0.01 worse than the analyst estimate of ($0.45).

For earnings history and earnings-related data on Iovance Biotherapeutics (IOVA) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Bernstein SocGen Group Upgrades X-Fab Silicon Foundries SE (XFAB:FP) to Outperform
• Barclays Starts DKSH Holding AG (DKSH:SW) at Overweight